Maddie Pascoe
BSc Psychology
Assistant Research Fellow
New Zealand Brain Research Institute, Christchurch
This person is no longer at the institute and this page is for historical access to their publications only
Publications
Provided on request for non-commercial personal use by researchers.
2023
(2023). The New Zealand Parkinson’s Progression Programme. Journal of the Royal Society of New Zealand, 53, 466-488. 10.1080/03036758.2022.2111448
(2023). Dimensions of apathy in Parkinson’s disease. Brain and Behaviour, e2862, 1-8. 10.1002/brb3.2862
2021
(2021). Higher perceived stress and exacerbated motor symptoms in Parkinson's disease during the COVID-19 lockdown in New Zealand. The New Zealand Medical Journal, 134, 44-51.
(2021). Neuropsychiatric symptoms are associated with dementia in Parkinson’s disease but not predictive of it. Movement Disorders Clinical Practice, 8, 390-399. 10.1002/mdc3.13151
2019
(2019). Beta amyloid deposition is not associated with cognitive impairment in Parkinson’s disease. Frontiers in Neurology, 10, 391. 10.3389/fneur.2019.00391
(2019). Altered grey matter volume, perfusion and white matter integrity in very low birthweight adults. NeuroImage: Clinical, 22, 101780. 10.1016/j.nicl.2019.101780
2018
(2018). The Symbol-Digit Modalities Test in mild cognitive impairment: evidence from Parkinson's disease patients. European Neurology, 79, 206-210. 10.1159/000485669
Abstracts and Short papers
2020
(2020). Neuropsychiatric symptoms are associated with dementia in Parkinson’s disease but not predictive of it. MedRxiv, 2020, 09, 01, 20186312. https://doi.org/10.1101/2020.09.01.20186312
2019
(2019). Sensorimotor integration assessment by the Symbol-Digit modalities test in patients with Parkinson’s disease. Neurosciences 24, 143. 10.17712/nsj.2019.2.20190002